China Biotech Services Holdings Limited (HKG:8037)

HKG:8037 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	683	498	742	1,108	1,329	1,256
Market Cap Growth	70.73%	-32.91%	-33.04%	-16.67%	5.85%	1.17%
Enterprise Value	858	622	678	1,090	1,342	1,314
Last Close Price	0.70	0.51	0.77	1.14	1.37	1.29
PE Ratio	-	-	-	4.29	68.57	41.63
PS Ratio	8.88	7.06	3.50	0.60	2.13	1.92
PB Ratio	3.22	2.05	1.51	1.34	2.85	2.45
P/TBV Ratio	6.85	3.95	2.49	2.61	6.86	9.12
P/FCF Ratio	-	-	5.61	2.96	46.99	4.25
P/OCF Ratio	-	-	3.87	2.30	32.82	2.98
EV/Sales Ratio	11.15	8.83	3.20	0.59	2.15	2.00
EV/EBITDA Ratio	-	-	-	1.21	5.48	5.87
EV/EBIT Ratio	-	-	-	1.29	7.08	6.77
EV/FCF Ratio	-7.60	-	5.12	2.91	47.43	4.45
Debt / Equity Ratio	1.01	0.78	0.21	0.10	0.14	0.21
Debt / EBITDA Ratio	-	-	-	0.09	0.26	0.45
Debt / FCF Ratio	-	-	0.76	0.22	2.37	0.36
Net Debt / Equity Ratio	0.95	0.70	0.06	-0.01	-0.18	-0.55
Net Debt / EBITDA Ratio	-3.21	-1.28	-0.39	-0.01	-0.35	-1.25
Net Debt / FCF Ratio	-1.79	-0.83	0.21	-0.03	-3.01	-0.95
Asset Turnover	0.13	0.12	0.20	1.70	0.77	0.99
Inventory Turnover	18.15	11.39	12.69	63.98	51.75	70.71
Quick Ratio	0.14	0.23	0.73	1.54	1.09	1.54
Current Ratio	0.18	0.33	1.64	1.61	1.22	1.64
Return on Equity (ROE)	-54.91%	-68.71%	-21.36%	109.19%	27.11%	40.61%
Return on Assets (ROA)	-8.08%	-15.34%	-6.85%	48.39%	14.71%	18.38%
Return on Invested Capital (ROIC)	-18.24%	-31.45%	-17.51%	115.24%	45.35%	59.30%
Return on Capital Employed (ROCE)	-22.00%	-43.40%	-23.20%	91.40%	39.50%	30.70%
Earnings Yield	-22.00%	-39.82%	-12.87%	23.30%	1.46%	2.40%
FCF Yield	-16.54%	-40.90%	17.84%	33.81%	2.13%	23.52%
Dividend Yield	-	-	-	0.88%	-	-
Buyback Yield / Dilution	-1.20%	-0.55%	-	0.15%	0.39%	-0.79%
Total Shareholder Return	-1.20%	-0.55%	-	1.03%	0.39%	-0.79%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.